RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancer
File(s)
Author(s)
Hoppe, Michal M
Tan, David SP
Lim, Diana GZ
Karnezis, Anthony
Huntsman, David
Type
Conference Paper
Date Issued
2017-10-01
Date Acceptance
2017-01-04
Citation
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
URI
DOI
ISSN
1535-7163
Publisher
American Association for Cancer Research
Journal / Book Title
MOLECULAR CANCER THERAPEUTICS
Volume
16
Issue
10
Copyright Statement
© 2017 American Association for Cancer Research.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412270800031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Publication Status
Published
Start Date
2017-01-04
Finish Date
2017-01-07
Coverage Spatial
San Diego, CA
Date Publish Online
2017-10-01